Research reveals a 6% annual increase in European colorectal cancer incidence rates among adults aged 20-39 years between 2008 and 2016. This trend is driven by increased risk factors such as sedentary lifestyles, obesity, and poor diets.
Researchers found a unique microbial signature for esophageal cancer that could help identify at-risk individuals and develop alternative therapeutic strategies. The study suggests that analyzing the oesophageal microbiota may provide innovative diagnostic tools to improve the management of this condition.
A randomized, placebo-controlled study has shown that cannabis oil can produce clinical remission in up to 65% of individuals with moderately severe Crohn's disease after 8 weeks of treatment. However, the improvement does not appear to result from a dampening down of the underlying inflammatory process.
A study reports that approximately half of young children with progressive familial intrahepatic cholestasis (PFIC) have received a liver transplant by age 10. Surgical biliary diversion was found to increase survival rates in children with mild or moderate PFIC2 mutations.
A new study found ginger effective in treating vomiting in children with acute gastroenteritis, leading to fewer lost school days and reduced hospitalizations. The trial compared the effectiveness of ginger with a placebo, showing significant reductions in vomiting episodes and school absences.
Targeted probiotic supplementation in breastfed infants reduces antibiotic resistance genes by 87.5%, including genes associated with respiratory, intestinal, urinary infections, chlamydia, and acne.
Researchers found that FAIMS technology can effectively differentiate between pancreatic cancer patients and healthy individuals, with a sensitivity and specificity of 85% and 75%, respectively. The test is non-invasive, affordable, and can analyze up to 20 urine samples per hour.
A population-based study found a 22% reduction in stomach cancer risk among those aged 60 and over who received antibiotic-based treatment for H. pylori infection compared to the general population. The study suggests that treating this type of bacterial infection in older adults can help reduce their risk of developing gastric cancer.
Research shows long-term aspirin use significantly reduces digestive cancer incidence, with substantial reductions in liver and oesophageal cancers. Aspirin use also shows promise in reducing risk of certain other cancers, while raising cardiovascular risk when stopped.
Researchers found a 400% increase in neoplasia detection in patients aged 45-49 compared to 40-44, with similar increases seen for polyps and adenoma detection. The findings support screening starting at 45 years old to detect colorectal cancer in young adults.
A new AI-assisted endoscopic system has been shown to automatically identify colorectal adenomas during colonoscopy, demonstrating a sensitivity of 94% and specificity of 79%. The system enables real-time optical biopsy, allowing for the complete resection of adenomatous polyps and preventing unnecessary polypectomy.
Experts from United European Gastroenterology call on European governments to develop early detection techniques for digestive cancers, including faecal microbiota screening and gastric cancer screening. The aim is to improve outcomes and save thousands of European lives.
A recent study reveals that many children with inflammatory bowel disease (IBD) are not meeting the recommended daily intake of calcium and vitamin D. Experts warn that this can lead to poor bone health, development issues, and increased risk of permanent height deficits.
Researchers identified a new test to predict the severity of IBD in children based on faecal microbiota profiles. The study found that children with more extensive IBD had distinct gut microbiota profiles, including higher levels of Clostridiales and Proteobacteria.
A study presented at the ESPGHAN conference warns that young children on a vegan diet without proper medical and dietary advice may experience vitamin B12, calcium, zinc, and high-quality protein deficiencies. These deficiencies can lead to devastating health effects, including irreversible cognitive damage and death.
A study finds that gluten-free items have a significantly higher energy content and different nutritional composition compared to their gluten-containing counterparts. This could impact children's growth and increase the risk of childhood obesity.
Pancreatic cancer is expected to become the third leading cause of death from cancer in the EU by 2017. The number of deaths from pancreatic cancer will overtake breast cancer mortality rates in the EU, with 91,500 estimated deaths next year.
A new global report calls for a 5-step plan to improve hygiene practices and reduce the burden of infectious diseases in children worldwide. The report aims to halve the incidence of diarrhoea and reduce common infections such as gastroenteritis, colds, and influenza in babies and children.
A pioneering new program could significantly improve quality of life for young adults living with inflammatory bowel disease (IBD). The Berliner TransitionsProgramm, a two-year transition from pediatric to adult care, has reported successful outcomes and is being adopted across Europe.
A new study has found that faecal bacterial profiles can be used to predict which IBS patients are most likely to benefit from a low-FODMAP diet. The research identified differences in gut bacteria composition between those who responded and did not respond to the diet.
The Rome IV classification introduces new diagnoses, emphasizes gut-brain interaction, and updates diagnostic criteria for functional gastrointestinal disorders. The Rome IV toolkit provides an interactive clinical decision-making tool for clinicians to optimize patient care.
Researchers have developed a new imaging technique using hyperspectral imaging to detect and characterize early cancerous changes in the gastrointestinal tract. The technique, which involves increasing color channels during endoscopy, has the potential to improve specificity of lesion identification.
A new study reveals that a protein in wheat triggers inflammation in tissues beyond the gut, contributing to the development of chronic health conditions. The consumption of ATIs may worsen symptoms of rheumatoid arthritis, multiple sclerosis, and non-coeliac gluten sensitivity.
A new treatment advance has significantly lowered the risk of disease progression or death among patients with previously treated, advanced midgut neuroendocrine tumors. The novel drug Lutetium-DOTATATE has been found to offer an 80% reduced risk of disease progression or death compared to octreotide LAR.
Healthcare professionals across Europe are urged to address alcohol misuse and dependence to prevent colorectal cancer (CRC). A growing European primary care study highlights the need for family doctors to identify and treat hazardous drinkers.
Experts at UEG Week 2015 reveal compelling evidence of the link between excess body weight and colorectal cancer risk. Men who gained at least 10 cm in waist circumference over 10 years experienced a nearly 60% increased CRC risk, with obesity doubling this risk for those with Lynch Syndrome.
New risk profiling approach aims to detect GI cancers, such as oesophageal adenocarcinoma, in early stages. The five-tier strategy involves lifestyle changes, non-invasive testing, and genetic analysis to tailor screening and prevention options for each individual.
Italian scientists discover higher blood levels of zonulin in patients with non-coeliac gluten sensitivity (NCGS) and irritable bowel syndrome (IBS), suggesting a role for the protein in developing these conditions. The findings may lead to new treatment strategies for NCGS and IBS.
A new capsule form of faecal microbiota transplantation (FMT) has been shown to be well-tolerated and effective in resolving diarrhoea in patients with difficult-to-treat C difficile infection. The study found a 90% rate of symptom resolution, suggesting that FMT could potentially supersede antibiotics as a treatment option.
A new study suggests that Symprove, a live multi-strain probiotic drink, can reduce intestinal inflammation in patients with ulcerative colitis. The results show significant reductions in faecal calprotectin levels and improvements in symptoms without observed side effects.
Researchers have made significant progress in understanding the pathophysiology of irritable bowel syndrome (IBS), leading to the development of novel molecular therapies. Current therapies are often ineffective or have unknown long-term efficacy, but new treatments show promise in treating IBS symptoms.
Scientists have identified two promising candidates for blood-borne biomarkers that could lead to a simple screening test. Abnormal DNA methylation patterns and microRNAs show promise in detecting colorectal cancer.
Two new pill-only regimens have been developed to treat genotype 1 hepatitis C, with a sustained virological response achieved in 90% of previously untreated patients and 82% of those who failed previous treatment. These regimens show promise as simpler, safer, and faster alternatives to current therapies.
A new study found that IBS patients process pain signals from the gut abnormally, with depressed patients showing reduced central pain inhibition. Depression may contribute to the development or maintenance of disturbed pain processing in IBS.
Fecal microbiota transplantation has been proven to be a safe and highly effective treatment for recurrent C. difficile infections, eradicating bacteria in around 90% of cases with good safety profiles. The technique is now officially recognized as an effective treatment for this difficult-to-treat infection.
A growing number of colorectal cancer deaths in Europe necessitates an increase in nurse endoscopy training, with regular screening reducing the risk by 20-30%. UEG and ESGENA are working together to standardize training requirements and improve workforce availability.